Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
167.9 USD | +0.53% | +0.61% | -7.03% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.03% | 9.33B | |
-3.81% | 184B | |
-0.80% | 108B | |
-2.80% | 67.82B | |
+4.17% | 51.05B | |
+9.31% | 44.67B | |
+3.40% | 41.78B | |
+2.33% | 26.78B | |
+4.34% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Repligen : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 EPS $0.52, vs. Street Est of $0.31